Guardian Pharmacy Valuation
| GRDN Stock | 20.33 1.07 5.00% |
At this time, the firm appears to be fairly valued. Guardian Pharmacy retains a regular Real Value of USD20.52 per share. The prevalent price of the firm is USD20.33. Our model calculates the value of Guardian Pharmacy from evaluating the firm fundamentals such as operating margin of (0.33) %, and Profit Margin of (0.07) % as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 9.7993 | Enterprise Value 1.3 B | Price Sales 1.0676 | Enterprise Value Revenue 1.0998 |
Fairly Valued
Today
Please note that Guardian Pharmacy's price fluctuation is not too volatile at this time. Calculation of the real value of Guardian Pharmacy is based on 3 months time horizon. Increasing Guardian Pharmacy's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Guardian Pharmacy is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guardian Stock. However, Guardian Pharmacy's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.33 | Real 20.52 | Hype 20.3 | Naive 21.32 |
The intrinsic value of Guardian Pharmacy's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Guardian Pharmacy's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Guardian Pharmacy Services, helps investors to forecast how Guardian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guardian Pharmacy more accurately as focusing exclusively on Guardian Pharmacy's fundamentals will not take into account other important factors: Guardian Pharmacy Cash |
|
Guardian Pharmacy Total Value Analysis
Guardian Pharmacy Services, is currently forecasted to have valuation of 1.29 B with market capitalization of 1.25 B, debt of 12.98 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Guardian Pharmacy fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.29 B | 1.25 B | 12.98 M |
Guardian Pharmacy Investor Information
About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.38. Guardian Pharmacy had not issued any dividends in recent years. Based on the key measurements obtained from Guardian Pharmacy's financial statements, Guardian Pharmacy Services, is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 63.4 M | 81.4 M |
|
| |||||
| Operating Income | 42.9 M | 47.1 M |
|
|
Guardian Pharmacy Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Guardian suggests not a very effective usage of assets in March.Guardian Pharmacy Ownership Allocation
The majority of Guardian Pharmacy outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardian Pharmacy to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardian Pharmacy Services,. Please pay attention to any change in the institutional holdings of Guardian Pharmacy as this could imply that something significant has changed or is about to change at the company.Guardian Pharmacy Profitability Analysis
The company reported the previous year's revenue of 1.05 B. Net Income was 23.9 M with profit before overhead, payroll, taxes, and interest of 231.84 M.About Guardian Pharmacy Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Guardian Pharmacy Services,. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Guardian Pharmacy based exclusively on its fundamental and basic technical indicators. By analyzing Guardian Pharmacy's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Guardian Pharmacy's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Guardian Pharmacy. We calculate exposure to Guardian Pharmacy's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Guardian Pharmacy's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 239.6 M | 193.2 M |
Guardian Pharmacy Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 60.8 M | |
| Shares Float | 9.1 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share 18.499 | Quarterly Revenue Growth 0.197 |
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.